Fine Organic Industries Limited Annual Report FY2026

Official PDF · AI Summary · Financial Analysis
Official Annual + Quarterly Filings · AI Business Intelligence
NSE: FINEORG
Sector: Chemicals
Industry: Specialty Chemicals
Source: NSE / BSE
Last Updated: 16 Jun 2026
Business Intelligence Report Verdict
High
Outlook: Positive

Quality Scores

Business Compounding
84/100
Compounder
89/100
Management
90/100
Governance
94/100
Cash Flow
95/100

Latest Quarterly Earnings Summary

No quarterly summary available yet.

AI Summary

Fine Organic Industries Limited is a dominant niche player in the oleochemical-based additives market, specializing in food, polymer, and specialty additives. The company has demonstrated a robust 10-year sales CAGR of 14% and a profit CAGR of 18%, underpinned by deep technical expertise and a low-cost, debt-free operation. While the recent 3-year performance shows a cyclical normalization (-8% sales growth), the underlying return on equity remains high at 17% and the balance sheet is pristine. The promoter holding remains at 75%, indicating strong alignment with minority shareholders. The…

Key Changes in FY2026

The company has transitioned from a localized additive manufacturer to a global leader in oleochemical-based green additives. Over the past decade, the portfolio has expanded from core polymer additives into high-value niches like Food Emulsifiers, Feed Nutrition, and CosPha (Cosmetics & Pharma) chemicals. Strategic capacity expansions, such as the Ambernath facility and the Patalganga plant, have significantly increased MTPA capabilities to meet rising global demand for plant-based derivatives. The evolution is characterized by moving up the value chain toward 'Green surfactants' and anti-crystallizers, shifting away from generic chemicals. This digital and strategic transformation is evidenced by the growing number of export destinations and a diversified customer base across 70+…

Management Commentary

Led by technical promoters, the management has successfully scaled from a family-led boutique manufacturer to a global supplier. The MD&A clarity is high, focusing consistently on product diversification into feed nutrition and pharma additives. Promoter alignment is maximum at the regulatory cap of 75%. Transparency is evidenced by regular quarterly investor calls and consistent reporting quality over the last 10 years. While conservative in guidance, the management has historically delivered profitable growth ahead of industrial averages. The focus on 'green chemistry' positions them well for future regulatory shifts in the EU and USA.

Financial Highlights

The financial trajectory is marked by high capital efficiency, with ROCE historically peaking at 65% in FY23 before normalizing to a still-superior 21.5%. Operating margins have remained resilient in the 17-27% range over the decade, reflecting pricing power and operational leverage. Revenue doubled from FY21 to FY23 during the specialty chemicals boom, and current normalization reflects a stable bottom-up demand despite global destocking. Interest coverage is exceptionally high due to negligible debt levels of only ₹68 Cr against reserves of over ₹2,600 Cr. The shift in tax rates around FY20-21 reflects the adoption of the newer tax regime, aiding net profit margins.

Major Opportunities

  • Virtually debt-free balance sheet
  • Consistently high ROE (3y avg 19.5%)
  • Strong promoter skin in the game (75%)

Major Risks

  • Raw material prices (vegetable oils) are volatile
  • Revenue growth has stalled/declined over 3-year period (-8% CAGR)
  • Operating margins under pressure (27% down to 20%)

About This Annual Report

The Fine Organic Industries Limited FY2026 Annual Report is the company's flagship annual disclosure, filed with NSE / BSE. It covers the full-year business review, management discussion & analysis (MD&A), audited financial statements, director's report, corporate governance report, auditor's report, risk factors, capital allocation, subsidiaries, related-party transactions and ESG initiatives. This page consolidates the official PDF and an AI-generated summary so investors can quickly grasp what changed vs. prior years — sales growth, margin trend, cash flow quality, capex, dividends and management outlook — without having to read the entire filing.

Why Use AI?

  • Summarises hundreds of pages into a focused executive briefing
  • Identifies year-on-year key changes automatically
  • Extracts management commentary and tone
  • Highlights top risks and opportunities
  • Compares business evolution vs. earlier years
  • Answers your questions in plain English via Ask AI

Frequently Asked Questions

Related Research

AI Top Insights — Premium

Unlock deeper AI Top Insights, advanced comparisons, downloadable reports and premium features.